| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2008.06.059 |
| P698 | PubMed publication ID | 18601967 |
| P2093 | author name string | Simon Wain-Hobson | |
| Susanna Celli | |||
| Monica Sala | |||
| Francesco Sala | |||
| Raffaella Greco | |||
| Pierre Langlade-Demoyen | |||
| Anna Kostrzak | |||
| Denise Guetard | |||
| Minerva Cervantes Gonzalez | |||
| P2860 | cites work | Identification of novel HLA-DR1-restricted epitopes from the hepatitis B virus envelope protein in mice expressing HLA-DR1 and vaccinated human subjects | Q45411048 |
| Optimisation of secretion of recombinant HBsAg virus-like particles: Impact on the development of HIV-1/HBV bivalent vaccines | Q45411804 | ||
| Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses | Q45507304 | ||
| A plant-derived edible vaccine against hepatitis B virus. | Q45746962 | ||
| HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferon-gamma and tumor necrosis factor-alpha | Q47835000 | ||
| Intestinal intraepithelial lymphocytes prevent pathogen-driven inflammation and regulate the Smad/T-bet pathway of lamina propria CD4+ T cells | Q47867677 | ||
| Prolonged antigen expression following DNA vaccination impairs effector CD8+ T cell function and memory development | Q51969070 | ||
| Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells | Q51993308 | ||
| Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques | Q57089572 | ||
| A Bone Marrow-Derived APC in the Gut-Associated Lymphoid Tissue Captures Oral Antigens and Presents Them to Both CD4+ and CD8+ T Cells | Q57227964 | ||
| Induction of Autoimmune Diabetes by Oral Administration of Autoantigen | Q57228112 | ||
| Production of hepatitis B surface antigen in transgenic plants for oral immunization | Q57235165 | ||
| H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies | Q73129213 | ||
| Oral Immunization of Human with transgenic lettuce Expressing Hepatitis B Surface Antigen | Q77441971 | ||
| A mouse model of human adaptive immune functions: HLA-A2.1-/HLA-DR1-transgenic H-2 class I-/class II-knockout mice | Q80828494 | ||
| Mucosal immunization using recombinant plant-based oral vaccines | Q82345610 | ||
| CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract | Q22242965 | ||
| Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract | Q22242981 | ||
| Pushing the limits of the scanning mechanism for initiation of translation | Q28216394 | ||
| Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection | Q29619124 | ||
| In vivo evaluation of the context sequence of the translation initiation codon in plants | Q33895184 | ||
| Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion | Q33932451 | ||
| Oral immunization with hepatitis B surface antigen expressed in transgenic plants | Q33944696 | ||
| Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives | Q34171016 | ||
| Mucosal dendritic cells | Q34611254 | ||
| Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection | Q35635026 | ||
| Subdominant CD8+ T-cell responses are involved in durable control of AIDS virus replication | Q35785115 | ||
| Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa | Q35849596 | ||
| Dendritic cells and immune responses to orally administered antigens | Q36055982 | ||
| Preventing intolerance: the induction of nonresponsiveness to dietary and microbial antigens in the intestinal mucosa | Q36075150 | ||
| HIV vaccine design: insights from live attenuated SIV vaccines | Q36343536 | ||
| Decimated or missing in action: CD4+ T cells as targets and effectors in the pathogenesis of primary HIV infection | Q36415765 | ||
| Plant-derived vaccines: a look back at the highlights and a view to the challenges on the road ahead | Q36445550 | ||
| Oral tolerance and allergic responses to food proteins | Q36466994 | ||
| Problems and emerging approaches in HIV/AIDS vaccine development | Q36758574 | ||
| Tolerogenic dendritic cells and regulatory T cells: a two-way relationship | Q36788761 | ||
| Expression of hepatitis B surface antigen in transgenic plants | Q37337644 | ||
| Acute HIV infection: it takes more than guts | Q37446729 | ||
| Production of recombinant HIV-1/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine | Q40058510 | ||
| Simian immunodeficiency virus promoter exchange results in a highly attenuated strain that protects against uncloned challenge virus | Q40468654 | ||
| Hepatitis B surface antigen (HBsAg) expression in plant cell culture: Kinetics of antigen accumulation in batch culture and its intracellular form | Q40694013 | ||
| Muscle-specific expression of hepatitis B surface antigen: no effect on DNA-raised immune responses | Q40942046 | ||
| In HIV-1 pathogenesis the die is cast during primary infection | Q43716538 | ||
| Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO mice | Q43760325 | ||
| Immunogenicity of a novel, bivalent, plant-based oral vaccine against hepatitis B and human immunodeficiency viruses | Q44280479 | ||
| A prospective randomized controlled trial of structured treatment interruption in HIV-infected patients failing highly active antiretroviral therapy (Canadian HIV Trials Network Study 164). | Q44790426 | ||
| Immunogenicity of a plant-derived edible rotavirus subunit vaccine transformed over fifty generations | Q45065706 | ||
| P433 | issue | 35 | |
| P304 | page(s) | 4477-4485 | |
| P577 | publication date | 2008-07-02 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Immunogenicity and tolerance following HIV-1/HBV plant-based oral vaccine administration | |
| P478 | volume | 26 |
| Q84573785 | HIV-1 derived peptides fused to HBsAg affect its immunogenicity |
| Q54364542 | Immunogenicity of chloroplast‐derived HIV‐1 p24 and a p24‐Nef fusion protein following subcutaneous and oral administration in mice |
| Q35960908 | Immunological Characterization of Plant-Based HIV-1 Gag/Dgp41 Virus-Like Particles |
| Q27001897 | Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infection |
| Q22241377 | Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routes |
| Q84089776 | Oral administration of low doses of plant-based HBsAg induced antigen-specific IgAs and IgGs in mice, without increasing levels of regulatory T cells |
| Q38036581 | Overview of Plant-Made Vaccine Antigens against Malaria |
| Q91346436 | Plant lyophilisate carrying S-HBsAg as an oral booster vaccine against HBV |
| Q37776722 | Plant-based vaccines against human hepatitis B virus |
| Q36888029 | Plant-derived virus-like particles as vaccines |
| Q26783111 | Plant-made oral vaccines against human infectious diseases-Are we there yet? |
| Q28073401 | The Last Ten Years of Advancements in Plant-Derived Recombinant Vaccines against Hepatitis B |
| Q33870122 | Vaccination via Chloroplast Genetics: Affordable Protein Drugs for the Prevention and Treatment of Inherited or Infectious Human Diseases |
| Q37810695 | Vaccine production in plant systems — An aid to the control of viral diseases in domestic animals: A review |
| Q38059059 | Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development |
Search more.